How to Qualify for Medical Weight Loss: Eligibility Requirements Explained

GLP-1 weight loss medications are prescription drugs — not supplements or over-the-counter products. Accessing them through a legitimate telehealth program requires meeting medical eligibility criteria that are grounded in the same clinical guidelines used by in-person physicians.

Understanding these criteria in advance lets you enter the process with realistic expectations and prepare appropriately for your intake evaluation.

BMI-Based Eligibility Criteria

The FDA-approved indications for GLP-1 weight loss medications establish specific BMI thresholds. Most telehealth programs follow these guidelines:

• BMI ≥ 30 — qualifies on BMI alone (clinical obesity)
• BMI ≥ 27 with at least one weight-related comorbidity — qualifies with a qualifying health condition

BMI is a starting point, not the complete picture. Many programs also consider waist circumference, metabolic markers, and symptom burden when evaluating candidates near eligibility thresholds.

Qualifying Comorbidities (BMI 27+)

If your BMI is between 27 and 29.9, the following conditions typically qualify you for GLP-1 prescription:

• Type 2 diabetes or prediabetes
• High blood pressure (hypertension)
• High cholesterol or dyslipidemia
• Obstructive sleep apnea
• Cardiovascular disease history
• Non-alcoholic fatty liver disease (NAFLD)
• Polycystic ovary syndrome (PCOS)
• Osteoarthritis related to weight bearing

The Medical Intake Process

Telehealth weight loss programs evaluate eligibility through a structured intake process. Here is what to expect:

1. Health History Questionnaire: Covers current medications, past medical history, family history of relevant conditions, and a detailed review of weight history.
2. Vital Statistics: Height, weight, and BMI calculation. Many programs accept self-reported values for initial screening, with confirmation during ongoing care.
3. Contraindication Screening: Your intake responses are reviewed for conditions that preclude GLP-1 prescribing (see below).
4. Lab Review: Some programs require baseline metabolic panels, others order them post-approval. Labs assess glucose, lipids, kidney function, and thyroid status.
5. Clinician Review: A licensed physician, NP, or PA reviews your complete intake and either approves treatment, requests additional information, or declines with explanation.

Contraindications: Who Does Not Qualify

Certain conditions preclude GLP-1 prescribing regardless of BMI. Responsible providers screen for all of the following:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Active or recent pancreatitis
• Severe gastrointestinal disease (e.g., gastroparesis)
• Pregnancy or active breastfeeding
• Type 1 diabetes
• Severe kidney or liver disease (depending on medication and dose)
• Active eating disorder (anorexia, bulimia) requiring specialized care

What Happens After Approval

Once a clinician approves your prescription:

1. A dosing protocol is created — typically starting at the lowest dose with gradual escalation over weeks to months
2. Medication is shipped to your address from a licensed pharmacy
3. Follow-up check-ins are scheduled to assess tolerance and progress
4. Dose adjustments are made based on your response and side effect profile
5. Ongoing labs may be ordered at intervals to monitor safety

Frequently Asked Questions

What BMI do I need for GLP-1 medications?

BMI of 30 or higher qualifies on its own. BMI 27–29.9 qualifies with at least one weight-related health condition such as high blood pressure, prediabetes, or high cholesterol.

Can I qualify if I am only slightly overweight?

At BMI 27+, qualifying comorbidities make you eligible. Below BMI 27, current FDA-approved indications do not apply. Some providers are more flexible, but legitimate programs follow established clinical guidelines.

Will I need to submit labs before getting approved?

Requirements vary by program. Some require labs before prescribing; others prescribe first and order labs as part of ongoing care. Programs that order baseline labs provide better clinical oversight.

What if I was denied?

Denial may reflect a contraindication, insufficient information, or a BMI below threshold. Request a clear explanation. If you disagree, a second opinion with another clinician is entirely reasonable.

Does my primary care doctor need to be involved?

Telehealth programs provide independent medical oversight — you do not need a referral. However, informing your primary care provider is always good practice for coordinated care.

Compare GLP-1 Weight Loss Programs →